CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-06-18 | DEMARTINI DAVID Director | Grant or award · Stock Option | +50,000 | $0.10 | $5K | 100,000 |
| 2013-06-18 | DEMARTINI DAVID Director | Grant or award · Stock Option | +50,000 | $0.10 | $5K | 50,000 |
| 2011-12-02 | DEMARTINI DAVID Director | Purchase · Convertible Debenture | +285,714 | $0.40 | $114K | 285,714 |
| 2011-07-12 | DEMARTINI DAVID Director | Purchase · Option | +100,000 | $0.35 | $35K | 100,000 |
| 2011-06-08 | DEMARTINI DAVID Director | Option exercise | +1,500,000 | $0.20 | $300K | 3,281,250 |
| 2011-06-08 | DEMARTINI DAVID Director | Option exercise · Warrant | −1,500,000 | $0.20 | $300K | 0 |
Page 1 of 1 · 6 trades